Midterm outcomes of venovenous extracorporeal membrane oxygenation as a bridge to lung transplantation: Comparison with nonbridged recipients

@article{Sef2022MidtermOO,
  title={Midterm outcomes of venovenous extracorporeal membrane oxygenation as a bridge to lung transplantation: Comparison with nonbridged recipients},
  author={Davorin Sef and Alessandra Verzelloni Sef and Vladimir Trkulja and Binu Raj and Nicholas James Lees and Christopher P. Walker and Jerry Mitchell and Mario Petrou and Fabio de Robertis and Ulrich Stock and Ian McGovern},
  journal={Journal of Cardiac Surgery},
  year={2022},
  volume={37},
  pages={747 - 759}
}
Venovenous extracorporeal membrane oxygenation (VV‐ECMO) is increasingly being used in acutely deteriorating patients with end‐stage lung disease as a bridge to transplantation (BTT). It can allow critically ill recipients to remain eligible for lung transplants (LTx) while reducing pretransplant deconditioning. We analyzed early‐ and midterm postoperative outcomes of patients on VV‐ECMO as a BTT and the impact of preoperative VV‐ECMO on posttransplant survival outcomes. 

References

SHOWING 1-10 OF 49 REFERENCES

Peripheral femoral venoarterial extracorporeal membrane oxygenation as bridge to heart‐lung transplant omne iter incipit primus

A 56‐year‐old male with interstitial lung disease and severe secondary pulmonary hypertension is presented, who was successfully bridged to HLT with ambulatory femoral VA‐ECMO.

Extracorporeal membrane oxygenation in the pre and post lung transplant period.

This review provides an insight into the current outcomes and best practices for utilization of ECMO in the pre- and post-lung transplantation period.

Growing Experience with Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation

Overall, successfully bridged patients can derive a tangible benefit, albeit with considerable consumption of resources, but early morbidity and mortality are high and the failure to bridge to transplant is significant.

Efficacy of extracorporeal membrane oxygenation as a bridge to lung transplantation.

Outcome of Extracorporeal Membrane Oxygenation as a Bridge To Lung Transplantation: An Institutional Experience and Literature Review

Awake and ambulatory ECLS provides the best prognosis for these high-risk patients with end-stage lung disease on the transplant waiting list, and data show significantly lower survival in this high- risk group compared to patients transplanted without preoperative EclS.

Early airway dehiscence: Risk factors and outcomes with the rising incidence of extracorporeal membrane oxygenation as a bridge to lung transplantation

Preoperative recipient/donor risk factors and outcomes in patients with and without airway dehiscence are compared and the effect of extracorporeal membrane oxygenation (ECMO) on the incidence of AD is analyzed.

Improving Outcomes in Bridge-to-Transplant: Extended Extracorporeal Membrane Oxygenation Support to Obtain Optimal Donor Lungs for Marginal Recipients.

Successful lung transplantation after ECMO as bridge-to-transplant can be achieved, even in patients with prolonged support times, however, bridging time of less than 30 days is crucial for success.

Experience of extracorporeal membrane oxygenation as a bridge to lung transplantation in France.

  • M. LafargeP. Mordant H. Mal
  • Medicine
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • 2013